Network analysis to estimate central insomnia symptoms among daytime workers at-risk for insomnia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 09 2023
Historique:
received: 25 04 2023
accepted: 28 09 2023
medline: 5 10 2023
pubmed: 30 9 2023
entrez: 29 9 2023
Statut: epublish

Résumé

Although insomnia complaints are associated with mental health problems and reduced work productivity, the central insomnia symptoms in workers at-risk for insomnia remain unclear. This study aimed to identify the central insomnia symptoms among daytime workers at risk for insomnia. The participants were 881 Japanese daytime workers at-risk for insomnia with a mean age of 49.33 ± 9.92 years. At-risk for insomnia was defined as an Athens Insomnia Scale score of six or higher. The Athens Insomnia Scale was used as a screening for at-risk insomnia because it has higher sensitivity and specificity than other insomnia screening scales. The Insomnia Severity Index is recommended as a mechanism of insomnia and an outcome measure; therefore, a network analysis was conducted with the seven items of the Insomnia Severity Index. The important variables in the connections between insomnia symptoms were estimated from centrality indices, which were interpretable only for strength. The strength value results suggest that difficulty staying asleep and worry about sleep problems were the central insomnia symptoms. The connections were stronger for difficulty staying asleep and problem waking up too early, difficulty staying asleep and difficulty falling asleep, and interference with daytime functions and noticeable to others. Worry about sleep problems was strongly associated with variables other than nocturnal insomnia symptoms. Therefore, difficulty staying asleep and worry about sleep problems are important variables in daytime workers at-risk for insomnia and are key points for improvement or exacerbation of insomnia symptoms.

Identifiants

pubmed: 37775548
doi: 10.1038/s41598-023-43802-7
pii: 10.1038/s41598-023-43802-7
pmc: PMC10542340
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16406

Informations de copyright

© 2023. Springer Nature Limited.

Références

Behav Res Ther. 2022 Jun;153:104100
pubmed: 35462241
J Psychosom Res. 2016 Aug;87:85-92
pubmed: 27411756
Sleep Med Rev. 2023 Oct;71:101839
pubmed: 37657127
Psychiatry Clin Neurosci. 2013 Sep;67(6):420-5
pubmed: 23910517
JAMA Netw Open. 2020 Nov 2;3(11):e2018782
pubmed: 33156345
J Psychosom Res. 2000 Jun;48(6):555-60
pubmed: 11033374
Sleep Med. 2021 Nov;87:38-45
pubmed: 34508986
Sleep Med Rev. 2018 Apr;38:3-16
pubmed: 28392168
Sleep. 2006 Sep;29(9):1155-73
pubmed: 17040003
J Sleep Res. 2023 Feb;32(1):e13711
pubmed: 36054731
Brain Sci. 2017 Mar 02;7(3):
pubmed: 28257084
Sleep Med. 2016 Sep;25:130-138
pubmed: 27823706
Sleep. 2020 May 12;43(5):
pubmed: 31789381
Behav Res Methods. 2018 Feb;50(1):195-212
pubmed: 28342071
Behav Res Ther. 2016 Nov;86:95-104
pubmed: 27424882
Sleep. 2015 Jan 01;38(1):119-26
pubmed: 25325466
Nat Hum Behav. 2021 Jan;5(1):113-122
pubmed: 33199855
BMJ Open. 2014 Mar 18;4(3):e004183
pubmed: 24643168
J Consult Clin Psychol. 2021 Apr;89(4):364-370
pubmed: 33630618
J Affect Disord. 2022 Aug 15;311:181-188
pubmed: 35594975
Behav Res Ther. 2002 Aug;40(8):869-93
pubmed: 12186352
Nat Sci Sleep. 2021 Oct 28;13:1921-1930
pubmed: 34737660
Sleep Med. 2023 Jan;101:505-514
pubmed: 36527942
Front Psychol. 2021 Jun 21;12:677538
pubmed: 34234716
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Clin Psychol Rev. 2020 Aug;80:101873
pubmed: 32777632
Biopsychosoc Med. 2022 Jun 3;16(1):13
pubmed: 35658925

Auteurs

Yuta Takano (Y)

Department of Somnology, Tokyo Medical University, 5-10-10 Yoyogi, Shibuya-ku, Tokyo, 151-0053, Japan. takano.yuta.3z@tokyo-med.ac.jp.
Japan Somnology Center, Neuropsychiatric Research Institute, Tokyo, Japan. takano.yuta.3z@tokyo-med.ac.jp.

Rui Ibata (R)

Graduate School of Psychological Science, Health Sciences University of Hokkaido, Hokkaido, Japan.
Goryokai Medical Corporation, Hokkaido, Japan.

Norihito Nakano (N)

School of Psychological Science, Health Sciences University of Hokkaido, Hokkaido, Japan.

Yuji Sakano (Y)

Sapporo CBT & EAP Center, Goryokai Medical Corporation, Hokkaido, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH